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Cells lacking the exosome-associated protein Rrp47 show simi-
lar defects in stable RNA processing to those observed in the ab-
sence of the catalytic subunit Rrp6, but the precisemechanism(s)
by which Rrp47 functions together with Rrp6 remains unclear.
Deletion complementation analyses defined anN-terminal region
of Rrp47, largely coincident with the bioinformatically defined
Sas10/C1D domain, which was sufficient for protein function in
vivo. In vitro protein interaction studies demonstrated that this
domain of Rrp47 binds the PMC2NT domain of Rrp6. Expression
of the N-terminal domain of Rrp47 in yeast complementedmost
RNA-processing defects associated with the rrp47 mutant but
failed to complement the defect observed in 3-endmaturation of
box C/D small nucleolar RNAs. Consistent with these results,
protein capture assays revealed an interaction between the C-
terminal region of Rrp47 and the small nucleolar ribonucleopro-
teins Nop56 andNop58. Filter binding assays demonstrated that
deletion of the lysine-rich sequence at the C terminus of Rrp47
blocked RNA binding in vitro. Furthermore, a proteinmutated
both at the C terminus andwithin the N-terminal domain
showed a synergistic defect in RNA binding without impacting on
its ability to interact with Rrp6. These studies provide evidence
for a role of Rrp47 in registering a small nucleolar ribonucleopro-
tein particle assembly, functionally characterize the Sas10/C1D
domain of Rrp47, and show that both the C terminus of Rrp47
and the N-terminal domain contribute to its RNA-binding
activity.
The exosome ribonuclease complex was initially character-
ized through its function in the processing of 3-extended
precursors to stable RNAs such as 5.8 S rRNA, small nucleo-
lar RNAs (snoRNAs),5 and small nuclear RNAs (snRNAs) and
in the degradation of excised RNA fragments that are released
during such RNA-processing reactions (1, 2). It has since be-
come clear that the exosome also plays a crucial role in nu-
clear RNA surveillance mechanisms that recognize and de-
grade transcripts that are incorrectly processed, that do not
receive the appropriate post-transcriptional modification, or
that are not correctly assembled into ribonucleoprotein parti-
cles (3–5). More recently, studies have shown that the exo-
some is responsible for the degradation of short-lived tran-
scripts that are the result of pervasive transcription
throughout the genome (6–9). In the cytoplasm, the exosome
also functions in normal mRNA turnover and in translation-
coupled RNA surveillance mechanisms. The role of the exo-
some in RNA-processing and surveillance pathways has been
the subject of a number of recent reviews (3, 4, 10–14).
Catalytic activity of the eukaryotic exosome is attributed to
two subunits, Rrp44/Dis3 and Rrp6 (15, 16). Rrp44 is a mem-
ber of the RNase II family of 33 5 exoribonucleases but
also has an endonucleolytic activity associated with its N-ter-
minal PIN domain (17–19). Rrp6 is related to another bacte-
rial 33 5 exoribonuclease, RNase D (20–22). These en-
zymes have differing substrate preferences in vitro, and yeast
strains mutant for Rrp44 or Rrp6 show distinct stable RNA-
processing phenotypes, with rrp6mutants accumulating char-
acteristic precursor species, including a 3-extended form of
5.8 S rRNA and adenylated forms of snoRNAs and U6 snRNA
(1, 2, 6, 23, 24). RNA analyses of yeast mutants expressing a
C-terminally truncated Rrp6 mutant that cannot bind stably
to the exosome suggest that this enzyme might carry out
some of its functions independently of the exosome complex
(25).
Yeast strains lacking the small nuclear protein Rrp47 (also
known as Lrp1) show comparable RNA-processing pheno-
types to those observed in the absence of Rrp6, and Rrp47 is
found associated with exosome complexes that contain Rrp6
(26–29). We have previously shown that Rrp47 interacts di-
rectly with the N-terminal region of Rrp6 (30) comprising the
PMC2NT domain (31). Like other exosome factors, Rrp47 is
conserved throughout eukaryotes, and the homologous hu-
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man protein, C1D, functions in stable RNA-processing path-
ways and interacts with the Rrp6 homologous protein PM/
Scl-100 (32). Both Rrp47 and C1D have RNA- and DNA-
binding activity, with an apparent specificity for double-
stranded DNA and structured RNA substrates (30, 32, 33).
Rrp47 has been shown to bind both Rrp6 and nucleic acid
concomitantly, suggesting that it might promote Rrp6 activity
by enabling the enzyme to bind structural elements within
RNA (30).
Rrp47 lacks previously characterized domains that are asso-
ciated with nucleic acid- or protein-binding activity. In the
absence of available structural data for Rrp47, we initiated a
mutagenesis study to map the regions of the protein that are
required for its characterized RNA-processing functions in
vivo and for its Rrp6- and RNA-binding activities in vitro.
Mutually supportive data from biochemical and genetic ex-
periments define a domain within the N-terminal portion of
Rrp47 that can interact with Rrp6 and that is sufficient for
Rrp47 function in yeast. In contrast, stable binding of Rrp47
to RNA in vitro required the full-length protein. Finally, RNA
analyses of rrp47mutants and protein interaction studies in
vitro suggest an unexpected role for Rrp47 in sensing the as-
sembly of box C/D small nucleolar ribonucleoprotein
(snoRNP) particles.
EXPERIMENTAL PROCEDURES
Bioinformatics—The secondary structure of Rrp47 was pre-
dicted using the web server Phyre (34). Rrp47 homologous
sequences were identified by WU-BLAST2 using the EBI
server (35). Multiple sequence alignments were created using
ClustalW and viewed using Jalview (36).
Construction and Growth of Strains—Details of plasmid
constructions, primer sequences, and strain descriptions are
provided in the supplemental “Experimental Procedures.”
Plasmid constructs were generated by standard restriction
digestion cloning techniques or site-directed mutagenesis
using the QuikChange mutagenesis kit (Stratagene). Yeast
strains carrying plasmids were grown under standard selective
conditions, whereas strains expressing genomically encoded
tandem affinity purification-tagged proteins (Open Biosys-
tems) were grown in YPD medium (yeast extract, peptone,
and dextrose).
Expression and Purification of Recombinant Proteins—GST,
GST-22, GST-C, GST-PMC2NT, and His6-Rrp47 proteins
were induced in BL21(DE3)LysS cells, and cell lysates were
made in 20 mM HEPES, pH 7.6, 300 mM NaCl, 10 mM imidaz-
ole, and 1 mM PMSF as described previously (30). Full-length
His6-Rrp47 and the N* sextuple point mutant (E79A/R82G/
K84I/Y86S/K89M/K91I) were purified by nickel-nitrilotriace-
tic acid (Ni-NTA) affinity chromatography and ion exchange
chromatography over SP-Sepharose as described (30). For the
C, S100X, I162X, V176X, G181X, and N*G181Xmutant
Rrp47 proteins, the Ni-NTA eluates were dialyzed against 20
mM HEPES, pH 7.6, and 150 mM NaCl and passed over SP-
Sepharose beads, and the nonbound fraction was retained.
Proteins were analyzed by SDS-PAGE and Western blotting
using the anti-pentahistidine monoclonal antibody (Qiagen)
or anti-GST antiserum (Sigma).
Expression of the heteromeric His9-Nrd1MBP-Nab3 com-
plex was performed as described (37). This expression con-
struct does not encode the C-terminal 26 residues of Nrd1,
191 residues from the N terminus of Nab3, and 238 residues
from the C terminus of Nab3. The Nrd1Nab3 complex was
purified by Ni-NTA affinity chromatography and detected in
pulldown assays by Western blot analyses using monoclonal
antibodies against the His epitope (Qiagen) or MBP (Sigma).
Protein and RNA Analyses—The SL-AU RNA (ggguuuc-
cuucucaaacauucuguuugguagugaguaauuaaaaaugaauu) was
generated by in vitro transcription of EcoRI-linearized plas-
mid p299 using T7 RNA polymerase. Transcription products
were dephosphorylated by incubation with alkaline phospha-
tase, gel-purified, and 5-32P-labeled with [-32P]ATP using
T4 polynucleotide kinase. Yeast tRNAPhe (Sigma) was dephos-
phorylated and 5-labeled as described above. RNA-binding
experiments were performed using a modified double-filter
binding assay (38). Purified recombinant proteins were seri-
ally diluted in RNA-binding buffer (10 mM Tris-HCl, pH 8,
150 mM NaCl, 2 mM MgCl2, 0.1 mM EDTA, and 10% glycerol)
and 20-l aliquots were mixed with 5 l of 32P-labeled RNA
substrate (final concentration, 10 nM). After incubation on ice
for 10 min, the reaction mixtures were filtered through a dou-
ble membrane consisting of Hybond N overlaid with Hy-
bond C (GE Healthcare) using a Minifold II slot blot appara-
tus (Schleicher & Schüll) and washed three times with 0.5 ml
of binding buffer. RNA retained on each membrane was visu-
alized using a Storm PhosphorImager (GE Healthcare), and
the data were quantified using ImageQuant software (GE
Healthcare). Triplicate assays were performed in parallel.
Pulldown experiments using extracts from Escherichia coli
cells expressing recombinant GST-PMC2NT and Rrp47 pro-
teins were performed essentially as described (30). Yeast cell
extracts were made in lysis buffer comprising 10 mM Tris-
HCl, pH 7.6, 150 mM NaCl, and 5 mM MgCl2. Protein capture
assays were performed by adding 0.5 ml of cell extract from
yeast strains expressing epitope-tagged proteins to 20 l of
Ni-NTA beads or glutathione-Sepharose beads precharged
with recombinant protein. Binding reactions were carried out
for 2 h at 4 °C. After washing five times with 1 ml of cell lysis
buffer containing 0.1% Nonidet P-40 for 10 min, the beads
were routinely incubated with 1 g of RNase A for 30 min at
20 °C and then rewashed. Retained protein was eluted in 50 l
of elution buffer (20 mM HEPES, pH 7.6, and 300 mM NaCl
containing 250 mM imidazole or 25 mM reduced glutathione).
In the experiment shown in supplemental Fig. S3, proteins
from yeast cell extracts that were retained on Rrp47-charged
beads were treated with DNase I, micrococcal nuclease, or
RNase A before rewashing and elution with imidazole-con-
taining buffer. Samples were resolved by SDS-PAGE and ana-
lyzed by Western blotting using the peroxidase/anti-peroxi-
dase antibody (Sigma).
Total cellular RNA was resolved through 8% polyacryl-
amide gels containing 50% urea, transferred to a Hybond N
membrane, and hybridized with 5-32P-labeled oligonucleo-
tide probes as described (25). The probes used were as
follows: 5.8 S rRNA (o236), gcgttgttcatcgatgc; 5-external
transcribed sequence (ETS; o274), cgctgctcaccaatgg; snR38
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(o272), gagaggttacctattattacccattcagacagggataactg; snR50
(o494), ctgctgcaaattgctacctc; snR52 (o318), gtatcagagattgt-
tcacgctaatg; U6 (o517), atctctgtattgtttcaaattgaccaa; and SCR1
(o242), aaggacccagaactaccttg.
RESULTS
The N-terminal Sas10/C1D Domain of Rrp47 Is Sufficient
for Normal Growth—Yeast strains lacking Rrp47 exhibit a
moderate slow growth phenotype in selective medium (30),
whereas strains lacking both RRP47 and REX1 genes are non-
viable (27). To determine the region of Rrp47 required for
function in vivo, plasmids encoding N- or C-terminal deletion
mutants were assayed for their ability to complement the syn-
thetic lethality of rrp47 rex1 double mutants in a plasmid
shuffle assay using a host strain that also allowed visualization
of plasmid loss through a red/white colony-sectoring pheno-
type (39) and for their ability to rescue the slow growth phe-
notype of rrp47 single mutants. The deletion mutants gener-
ated in this study are depicted in Fig. 1.
Protein structure prediction analyses suggested that the
N-terminal two-thirds of Rrp47 are largely -helical in nature
(supplemental Fig. S1). We therefore initially generated and
tested a mutant encoding the N-terminal 120 residues, de-
noted C. This mutant fully complemented the synthetic le-
thality of the rrp47 rex1 double mutant in the colony-sec-
toring assay and plasmid shuffle assay (Fig. 2A and data not
shown), demonstrating that the C-terminal region of Rrp47 is
not required for the essential function of Rrp47 in vivo in the
absence of Rex1. Further consideration of the predicted sec-
ondary structure suggested possible looped regions within the
Rrp47 structure around residues 95–100 and 68–74. Trunca-
tion at Ser-100 generated a construct that complemented the
synthetic lethality of the double mutant, with the colonies
obtained on medium containing 5-fluoroorotic acid for the
rrp47 rex1 double mutant that expressed the S100X rrp47
allele being of similar size to the wild-type control (Fig. 2B).
Truncation at Val-70 also complemented the rrp47 rex1
double mutant, but the colonies obtained were significantly
smaller. A slightly larger C-terminal truncation (L60X) failed
to support growth (Fig. 2B). Consistent with these data,
rrp47 transformants expressing the S100Xmutant grew
comparably to cells expressing the wild-type allele, whereas
V70X and L80Xmutants only partially restored the slow
growth phenotype of the rrp47 strain, and the L60Xmutant
grew at a rate comparable with the vector-transformed con-
trol (Fig. 2C). A short deletion (2–9) at the N terminus al-
lowed complementation in the plasmid shuffle assay and res-
cued the slow growth phenotype, whereas the larger 2–19
deletion did not (Fig. 2, B and C). The region of Rrp47 that is
required for function in vivo, as defined by these genetic
complementation assays, closely maps to residues 10–89,
which constitute the bioinformatically predicted Sas10/C1D
domain (Pfam accession number PF04000) (40, 41) (see Fig.
1). We conclude from these data that residues 10–100 of
Rrp47, encompassing the Sas10/C1D domain, are critical for
protein function in vivo.
The Sas10/C1D Domain of Rrp47 Binds Rrp6—We had pre-
viously shown that recombinant Rrp47 binds to the N-termi-
nal PMC2NT domain of Rrp6 in E. coli cell lysates (30). To
test whether the Sas10/C1D domain of Rrp47 is sufficient for
this interaction with Rrp6, purified His-tagged full-length
protein and the C mutant were added to beads charged with
GST or GST-PMC2NT fusion protein. Both purified full-
length Rrp47 and the C construct bound to the GST-tagged
PMC2NT domain, whereas neither protein was retained on
beads charged with GST (Fig. 3A). As observed previously
(30), a number of polypeptides shorter than the 50-kDa
GST fusion of the Rrp6 N-terminal domain were detected
upon Western blot analysis, which presumably arise through
proteolytic degradation. The S100X truncated Rrp47 protein
was stably expressed and also bound to the GST-PMC2NT
fusion protein. In control reactions, the unrelated Nrd1Nab3
protein complex failed to purify with the tagged Rrp6 N-ter-
minal domain (Fig. 3B). Similar results were obtained when
pulldown assays were performed on nonfractionated cell ly-
sates containing the recombinant proteins (data not shown).
FIGURE 1. Mutations generated in Rrp47. The position of the Sas10/C1D
domain within the Rrp47 protein and the sequence of the lysine-rich C-ter-
minal peptide are indicated. The scale indicates the position along the
length of the protein in amino acid residues. The coding regions present in
each of the C- or N-terminal truncation mutants is indicated; truncations
that encroach into the Sas10/C1D domain or the lysine-rich C-terminal pep-
tide are shown by serrated lines.
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Proteins with more extensive C-terminal truncations (L80X
and V70X) showed a specific but progressively decreasing
level of binding to the GST-PMC2NT fusion protein but were
not expressed at sufficient levels to allow a direct comparative
analysis using the binding assay (data not shown).
Both N- and C-terminal Regions of Rrp47 Contribute to
RNA Binding—We then asked whether the N-terminal region
of Rrp47 has RNA-binding activity. Filter binding assays were
performed on full-length Rrp47 or C-terminally truncated
mutants using either yeast tRNAPhe or a model-structured
RNA (denoted SL-AU) comprising the stem-loop at the 5-
end of the yeast internal transcribed sequence 2 (42) linked to
a 3-A/U-rich sequence.
Consistent with previous gel shift assays (30), full-length
Rrp47 bound to tRNAPhe and the SL-AU RNA substrates with
an apparent dissociation constant of 1 M (as calculated
using the concentration of the monomeric protein) (Fig. 4, A
and B) and showed no binding activity with a control sub-
strate transcribed from the polylinker of a cloning vector
(data not shown). This selective binding probably reflects the
degree of structure in the RNAs assayed because Rrp47 has
previously been shown to bind structured RNAs but not
poly(A) (30). In contrast to the wild-type protein, the C mu-
tant showed no significant binding to either tRNAPhe or the
SL-AU RNA substrates (Fig. 4, A and B). The C-terminal re-
gion of Rrp47 and its homologous proteins are typically very
basic, with 12 of the final 22 amino acids in the protein from
Saccharomyces cerevisiae being either lysine or arginine resi-
dues (shown schematically in Fig. 1; for a sequence alignment,
see supplemental Fig. S2). Mutant proteins lacking the C-ter-
minal 22 residues (denoted I162X) or nine residues (denoted
V176X) showed no detectable RNA-binding activity, whereas
a mutant lacking only the last four residues (denoted G181X)
exhibited a substantial decrease in RNA-binding activity (Fig.
4, A and B). A GST fusion of the C-terminal 22 residues
showed weak nonspecific binding activity to all RNA sub-
strates tested, including the polylinker transcript (data
not shown). Thus, the basic C terminus of Rrp47 is required
for stable interaction with RNA but is, in itself, not sufficient
for the stability and specificity of binding.
There are several well conserved, charged, or aromatic
amino acid residues within the N-terminal region of Rrp47
that lie clustered within the primary sequence, namely Glu-
79, Arg-82, Lys-84, Tyr-86, Lys-89, and Lys-91 (supplemental
Fig. S2). We mutated these residues, singularly and in combi-
nation, and tested the resultant mutant proteins for their abil-
ity to interact with RNA. The single-point mutants E79A,
R82A, K84A, Y86A, K89A, and K91A showed no defect in
RNA-binding activity in vitro (data not shown), and neither
did a sextuple mutant wherein each of the above residues was
mutated (denoted N*) (Fig. 4B). However, combining the sex-
tuple mutant with the compromised G181Xmutant (denoted
FIGURE 2. The N-terminal Sas10/C1D domain of Rrp47 is required for
protein function. A, colony-sectoring assay. An rrp47 rex1 double mu-
tant harboring a plasmid-borne copy of the RRP47 gene was transformed
with plasmids encoding the wild-type RRP47 gene, the C mutant, and a
vector control. Loss of the original plasmid through growth on YPD was
followed using the red/white colony-sectoring assay. B, plasmid shuffle as-
say. The rrp47 rex1 double mutant was transformed with plasmids en-
coding S100X, V70X, L60X, 2–9, and 2–19 rrp47 truncations and then
grown on solid medium containing 5-fluoroorotic acid to purge the cells of
the original RRP47 plasmid. C, growth rate analyses. An rrp47 strain was
transformed with plasmids encoding rrp47 truncation mutants, the wild-
type RRP47 gene, or the vector, and the growth rates of the resultant trans-
formants were measured in selective medium. Growth assays were per-
formed in duplicate with the average values plotted. The r2 values for all
individual data sets lay between 0.995 and 0.999.
FIGURE 3. The N-terminal domain of Rrp47 binds to Rrp6. A, pulldown
assays of His-tagged full-length (WT), S100X, and C Rrp47 proteins with a
GST fusion of the PMC2NT domain of Rrp6 (lanes 1, 3, 5, and 7) and the GST
control (lanes 2, 4, and 6). Glutathione-Sepharose beads charged with 100
g of GST or GST fusion protein were washed and then incubated with 50
g of purified recombinant Rrp47. Eluates were resolved by SDS-PAGE and
analyzed by Western blotting using antibodies against the His6 epitope (up-
per panel) or GST (lower panel). The electrophoretic mobility of bait proteins
and molecular mass markers (in kDa) are indicated on the right and left of
the panels, respectively. B, pulldown assays of Rrp47 and the Nrd1Nab3
complex control with the GST-PMC2NT fusion protein. Equivalent amounts
of input, supernatant (sup.) and eluate fractions were analyzed by Western
blotting using epitope tag-specific antibodies. Proteins detected in the
Western blot analyses are indicated. Multiple bands were detected for the
GST-PMC2NT fusion protein in both panels because of proteolytic
degradation.
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N*G181X) caused an essentially complete loss of RNA-bind-
ing activity in the resultant protein (Fig. 4C). This effect does
not reflect a gross structural alteration of the N-terminal re-
gion in the N*G181Xmutant protein because the N*, G181X,
and N*G181Xmutants bound to the PMC2NT region of Rrp6
in a comparable manner to the wild-type protein in pulldown
assays (Fig. 4C). These results demonstrate that the N-termi-
nal region and the extreme C terminus both contribute to the
RNA-binding activity of Rrp47.
The C-terminal Region of Rrp47 Has a Specific Function in
snoRNAMaturation—Yeast rrp47 strains accumulate 3-
extended forms of 5.8 S rRNA and box C/D snoRNAs and are
defective in the degradation of the excised 5-ETS pre-rRNA
fragment (27, 28). To determine which regions of the Rrp47
protein are required for its function in these processes,
Northern blot hybridization analyses were performed on total
cellular RNA from a wild-type strain, an rrp47 strain, and a
series of N- and C-terminal rrp47 truncation mutants.
As reported previously (27, 28), the rrp47 mutant accu-
mulated the 3-extended 5.8 S  30 species to high levels,
with a corresponding decrease in the level of mature 5.8 S
rRNA, and accumulated readily detectable amounts of the
5-ETS fragment (Fig. 5). Consistent with previous data (28,
30), this mutant also showed significantly increased levels of a
3-unprocessed form of snR38 and expressed an snR38 spe-
cies slightly longer than the mature form of wild-type strains
(labeled snR38–3 and snR383, respectively, in Fig. 5, C and
D) and accumulated both discrete and diffuse snR38 species
of intermediate length. The rrp47 mutant also accumulated
extended U6 snRNA species. The diffuse extended forms ob-
served for U6 and snR38 are consistent with polyadenylated
forms of these RNAs previously observed in rrp6 mutants (1,
2, 6, 24).
Mutant rrp47 alleles encoding proteins that do not encom-
pass the complete Sas10/C1D domain (2–19, L40X, I50X,
L60X, V70X, L80X) exhibited RNA-processing phenotypes
that are characteristic of rrp47 mutants (Fig. 5, lanes 5–10).
These mutants either failed to complement the rrp47 allele
genetically or exhibited slow growth (Fig. 2 and data not
shown), and so their expression levels may well be compro-
FIGURE 4. RNA binding of Rrp47. A and B, filter binding saturation curves obtained for wild-type or mutant Rrp47 proteins with the SL-AU and tRNAPhe
substrates. All assays were performed in triplicate; the vertical bars indicate the range of values. The sextuple mutant (N*) carries the point mutations E79A,
R82G, K84I, Y86S, K89M, and K91I. C, upper panel, parallel filter binding assays of the G181X truncation mutant and the N*G181X mutant. The amount of ra-
diolabeled tRNA retained is plotted against the concentration of Rrp47 protein. Assays were performed in triplicate; the vertical bars indicate the ranges of
values. Center panel, pulldown assays of the purified proteins used in the RNA-binding assays. Purified Rrp47 proteins were incubated with beads charged
with GST control (lanes 1, 3, 5, and 7) or the GST-PMC2NT fusion protein (lanes 2, 4, 6, and 8), and the eluates were analyzed by SDS-PAGE and Western blot-
ting using the anti-His antibody. Lower panel, Coomassie Blue-stained SDS-polyacrylamide gel of the purified recombinant Rrp47 proteins used in these
assays.
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mised. In contrast, the S100Xmutant showed no defect in 5.8
S rRNA processing or 5-ETS degradation and did not accu-
mulate the extended forms of snR38 or U6 (Fig. 5, compare
lanes 10 and 11). Similarly, the 2–9 mutant showed no de-
tectable defect in 5.8 S rRNA processing or in the maturation
of box C/D snoRNAs and did not accumulate extended U6
snRNA species. These results correlate closely with the ge-
netic complementation analyses (Fig. 2) and suggest that N-
or C-terminal deletions that encroach into the N-terminal
Sas10/C1D domain either impact on Rrp47 expression levels
or inhibit Rrp47 function in stable RNA-processing and deg-
radation pathways in vivo.
Intriguingly, strains expressing the S100X, C, I130X, and
T140X rrp47mutants accumulated the snR383 species but
not the longer extended forms of snR38 (Fig. 5, C and D, lanes
11–14), showed no defect in 5.8 S rRNA processing or 5-ETS
degradation, and did not accumulate 3-extended forms of U6
snRNA. To test whether this effect was specific to intron-en-
coded snoRNAs, the blots were also hybridized with probes
complementary to sequences within the independently tran-
scribed snoRNAs snR50 and snR52. Slightly extended forms
of snR50 and snR52 also accumulated in the S100X, C,
I130X, and T140Xmutants, albeit to a lesser extent in the case
of snR52 (Fig. 5). Comparable phenotypes were observed for
other intron-encoded (snR39) and independently transcribed
(snR54 and snR13) snoRNAs (data not shown).
In contrast, strains expressing the longer S150X, I162X, and
G181Xmutant proteins showed little or no accumulation of
aberrant forms of any of the RNAs tested (Fig. 5, lanes 15–
17). Inspection of a multiple alignment of Rrp47 sequences
(supplemental Fig. S2) suggested that a short sequence show-
ing a very high degree of conservation across yeast species
(amino acids 128–144 in S. cerevisiae, consensus yeast se-
quence PAISKSNFQGKHTKFED) maps to the region around
position 140, with Ile-130, Ser-131, Phe-135, His-139, and
Phe-142 being highly conserved. The two phenylalanine at
positions 135 and 142 were individually mutated to alanine
residues, and RNA was analyzed from strains expressing the
mutant proteins. The F142A mutant showed a specific RNA-
processing defect in snoRNA 3-end maturation, with a
marked accumulation of the 3 species for snR38, snR50, and
snR52, whereas the F135A mutant had a considerably weaker
effect (Fig. 5, D–F, lanes 18 and 19). These data support a spe-
cific role for residues within the C-terminal region of Rrp47 in
the final maturation of box C/D snoRNAs and demonstrate
that the basic C terminus, although required for stable RNA
binding in vitro, is dispensable for RNA-processing functions
in vivo.
The C-terminal Region of Rrp47 Interacts with snoRNP
Proteins—To test whether the C-terminal region of Rrp47
mediates an interaction between the exosome and snoRNP
particles, we assayed immobilized recombinant Rrp47 for its
ability to bind epitope-tagged forms of the snoRNP proteins
Nop56 and Nop58 in yeast cell lysates. Both Nop56 and
Nop58 were readily detected in the eluate fractions from
beads charged with full-length Rrp47 but not in eluates from
beads charged with the C mutant (Fig. 6A). In control reac-
tions, the full-length and truncated Rrp47 proteins bound
full-length Rrp6, and both failed to retain a truncated Rrp6
mutant lacking the N-terminal PMC2NT domain. Both the
C-terminally tagged Nop56 and Nop58 proteins consistently
migrated on SDS-polyacrylamide gels as one major band with
additional, slower migrating, diffuse bands. The reason for
this is not clear but presumably reflects a common structural
FIGURE 5. RNA Analyses of rrp47 mutants. RNA was resolved through an
8% denaturing polyacrylamide gel and analyzed by Northern blot hybrid-
ization. Hybridization patterns were visualized by autoradiography. Lane 1,
RNA from a wild-type strain; lanes 2–19, RNA from an rrp47 strain trans-
formed with plasmids encoding rrp47 alleles, as indicated. Probes used
were complementary to the following RNAs: 5.8 S rRNA (A), 5-ETS (B), snR38
(C and D), snR50 (E), snR52 (F), U6 (G), and SCR1 (H). The major species de-
tected are indicated on the right. D shows a shorter exposure than C that
reveals the relative levels of snR38 and the 3-extended snR383 species.
SCR1 served as a loading control.
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feature in these proteins, such as the C-terminal KK(D/E) re-
peats (43). The beads were routinely incubated with RNase A
prior to elution of the retained material, and incubation with
micrococcal nuclease or DNase I also failed to release Nop56
from the Rrp47-charged beads (supplemental Fig. S3). To ad-
dress whether the C-terminal region of Rrp47 is sufficient for
this interaction, residues 121–184 were expressed as a GST
fusion (denoted GST-CT), and the resultant protein was as-
sayed for Nop56 and Nop58 binding as described above. The
GST-CT fusion protein bound to both Nop56 and Nop58
present in cell extracts, whereas no binding was observed for
the GST control to either snoRNP protein (Fig. 6B). These
experiments show that Rrp47 can bind to box C/D snoRNP
proteins in an RNase- and DNase-insensitive manner and that
the C-terminal region of Rrp47 is necessary and sufficient for
this interaction.
DISCUSSION
Genetic complementation assays and Northern blot analy-
ses of cellular RNAs from rrp47mutants provide independent
corroborative data sets demonstrating that the N-terminal
region of Rrp47 encompassing residues 10–100 comprises a
domain that is critical for its function. Biochemical protein
binding studies demonstrated that the N-terminal domain of
Rrp47 interacts directly with the PMC2NT domain of Rrp6.
These data are consistent with a key biochemical activity of
Rrp47 being its ability to interact with Rrp6. Indeed, previous
studies from our laboratory showed that the interaction with
Rrp6 is required for normal expression levels of Rrp47 (30).
This empirically determined N-terminal domain correlates
with the bioinformatically defined Sas10/C1D domain (resi-
dues 10–89) (40) that is also found in the 18 S rRNA synthe-
sis factors Sas10/Utp3 and Lcp5 (44, 45) and in the metazoan
protein neuroguidin, a factor involved in translational regula-
tion during neuronal development (41, 46). We have found no
evidence for an interaction between Sas10 or Lcp5 and Rrp6,6
but it remains feasible that Sas10/C1D family members inter-
act with PMC2NT-related domains within other proteins.
An alternative but not mutually exclusive hypothesis is that
the Sas10/C1D family may represent a group of RNA-binding
proteins. Both Sas10/Utp3 and Lcp5 are found associated
with U3 snoRNA, whereas neuroguidin is associated with the
mRNA cap-binding protein eIF4E and the mRNA polyadenyl-
ation element-binding protein CPEB and is therefore presum-
ably bound to mRNP particles. Our studies reported here
show that the RNA-binding activity of Rrp47 is dependent
upon both basic residues at the extreme C terminus of the
protein and residues within the N-terminal domain. Notably,
Sas10, Lcp5, and neuroguidin also have clusters of basic resi-
dues close to their C termini (45–47), and basic residues are
conserved across the Sas10/C1D domain family at positions
equivalent to Lys-84 and Lys-89 of Rrp47 (339 and 290 resi-
dues of all 382 available sequences being either lysine or argi-
nine at these positions, respectively) (Pfam accession number
PF04000) (41).
Given the RNA-binding activity of Rrp47 and the require-
ment for this protein in stable RNA-processing events, an
unexpected observation was that short truncations from the C
terminus of Rrp47 that prevented stable RNA binding in vitro
(e.g. the I162Xmutant) had no discernible effect on Rrp47-de-
pendent RNA-processing events in vivo. One interpretation of
these data would be that the RNA-binding activity of Rrp47 is
not strictly required for its function in cellular stable RNA-
processing pathways, perhaps because of redundancy with
other RNA-binding proteins. Alternatively, interactions with
other protein factors may enable the RNA-binding activity of
the Sas10/C1D domain of Rrp47 to be sufficient for protein
function in vivo.
Our data reveal specific interactions between the C-termi-
nal region of Rrp47 and proteins of box C/D snoRNP com-
plexes and demonstrate that rrp47mutants lacking the C-
terminal region have specific defects in final 3-maturation of
box C/D snoRNAs. Previous studies have revealed similar
snoRNA-processing phenotypes for conditional mutants of
the snoRNP proteins Nop58 and Nop1 (48, 49). The 3-ex-
tended snoRNAs have been shown to be generated by post-
transcriptional oligoadenylation (24). Together, these data
suggest a model (Fig. 7) wherein, during normal snoRNP as-
sembly, Rrp47 interacts with the RNP particle during 3-mat-
uration and allows release of the mature complex. Conversely,
if assembly of the snoRNP particle is delayed, the lack of in-
teraction between Rrp47 and the snoRNP particle promotes
snoRNA oligoadenylation and/or impedes the removal of the
oligoadenylate tail by Rrp6. Oligoadenylated snoRNAs can be
detected at low levels in wild-type cells, and transcriptional
pulse-chase analyses have shown that oligoadenylated prod-
6 M. Turner and P. Mitchell, unpublished data.
FIGURE 6. Rrp47 interacts with Nop56 and Nop58. Cell extracts from
yeast strains (5 mg of total protein) expressing tandem affinity purifica-
tion-tagged proteins were incubated with beads precharged with 500 g
of recombinant proteins. After binding, the beads were washed and then
incubated with RNase A prior to rewashing and elution of the retained pro-
tein. Equivalent fractions of cell extract and supernatant (sup.) and a 100-
fold equivalent of the eluate fractions were then resolved by SDS-PAGE and
analyzed by Western blotting. The epitope-tagged protein expressed in
yeast is indicated on the right. A, pulldown assays with full-length Rrp47,
the C mutant, and a vector control. Lysates from strains expressing
epitope-tagged full-length Rrp6 or an Rrp6 mutant protein lacking the
PMC2NT domain were used as positive and negative controls, respectively.
B, pulldown assays with a GST fusion of the C-terminal region of Rrp47 (GST-
CT) or GST alone.
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ucts are processed to mature snoRNAs in wild-type cells (24).
Thus, oligoadenylation represents a step in a productive proc-
essing pathway for at least a fraction of the snoRNA tran-
scripts under normal physiological conditions. Our results
point to an important novel function of Rrp47 as a sensor for
RNP assembly during 3-end maturation of snoRNAs.
Delays in RNA-processing or assembly pathways can facili-
tate targeting of RNA substrates to quality control systems
(50–52). In many cases, adenylation of RNA substrates is an
initial step in such RNA degradation mechanisms, some of
which involve Rrp6. Our data are consistent with the model
(24) that snoRNA adenylation stalls the fate of the RNA and
provides a kinetic opportunity for the delayed assembly of
RNP particles to be completed (Fig. 7). Indeed, adenylation of
stable RNAs during productive processing appears to be quite
widespread (2, 24, 53–55). Similar interactions to those de-
scribed here between Rrp47 and snoRNP proteins might also
underlie the coupling of RNP assembly and processing of
other RNAs.
To date, Rrp47 has been envisaged to function as an RNA-
binding protein that allows Rrp6 to degrade structured RNA
(13, 30). The data presented here reveal an unsuspected role
for Rrp47 in RNP substrate recognition during final 3-end
maturation of box C/D snoRNAs. It is tempting to speculate
that polyadenylated species that accumulate in rrp47 and
rrp6 mutants, such as primary snoRNA transcripts (24),
cryptic unstable transcripts, or extended forms of U6 snRNA
(6) (see Fig. 5), arise because of the absence of similar interac-
tions between the Sas10/C1D domain of Rrp47 and other fac-
tors involved in RNA transcription termination or processing.
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